186 related articles for article (PubMed ID: 35281807)
1. TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis
Shou Y; Liu Y; Xu J; Liu J; Xu T; Tong J; Liu L; Hou Y; Liu D; Yang H; Cheng G; Zhang X
Front Genet; 2022; 13():648134. PubMed ID: 35281807
[TBL] [Abstract][Full Text] [Related]
2. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
3. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
Lin H; Zeng W; Lei Y; Chen D; Nie Z
Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
[TBL] [Abstract][Full Text] [Related]
4. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
5. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W
Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
[TBL] [Abstract][Full Text] [Related]
7. Loss of
Liu Y; Wang H; Ni B; Zhang J; Li S; Huang Y; Cai Y; Mei H; Li Z
Cancer Manag Res; 2019; 11():1211-1220. PubMed ID: 30799948
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.
Wu ST; Sun GH; Hsu CY; Huang CS; Wu YH; Wang HH; Sun KH
Exp Biol Med (Maywood); 2011 Sep; 236(9):1022-9. PubMed ID: 21856755
[TBL] [Abstract][Full Text] [Related]
9. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
10. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
[TBL] [Abstract][Full Text] [Related]
11. POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway.
Jia YY; Yu Y; Li HJ
J Cancer; 2021; 12(14):4183-4195. PubMed ID: 34093819
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-195 inhibits proliferation and metastasis in renal cell carcinoma via regulating HMGA1.
Dong H; Sun S; Yan T; Liang C; Zhu J; Miao C; Qin C; Shao P; Wang Z; Li J; Li P
Am J Transl Res; 2020; 12(6):2781-2792. PubMed ID: 32655809
[TBL] [Abstract][Full Text] [Related]
13. PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis.
Chen J; Hua X; Chen H; Qiu X; Xiao H; Ge S; Liang C; Zhou Q
Aging (Albany NY); 2021 Dec; 13(24):25778-25798. PubMed ID: 34959223
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
[TBL] [Abstract][Full Text] [Related]
15. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
Meng K; Li Z; Cui X
J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
17. Trim24 prompts tumor progression via inducing EMT in renal cell carcinoma.
Jiang T; Mao H; Chen Q; Cao L; He Y; Gao X; Chen W; Zhang H
Open Med (Wars); 2020; 15(1):1153-1162. PubMed ID: 33336072
[TBL] [Abstract][Full Text] [Related]
18. Silencing of the long non-coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial-mesenchymal transition.
Xie W; Liu X; Chen Q; Ma M; Yang X; Gong B; Sun T; Chen J
Oncol Lett; 2019 Mar; 17(3):3173-3180. PubMed ID: 30867747
[TBL] [Abstract][Full Text] [Related]
19. The Histone Acetyltransferase MOF Regulates SIRT1 Expression to Suppress Renal Cell Carcinoma Progression.
Guo R; Liang Y; Zou B; Li D; Wu Z; Xie F; Zhang X; Li X
Front Oncol; 2022; 12():842967. PubMed ID: 35252011
[TBL] [Abstract][Full Text] [Related]
20. Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma.
Han KS; Li N; Raven PA; Fazli L; Ettinger S; Hong SJ; Gleave ME; So AI
Mol Cancer Ther; 2015 Apr; 14(4):1024-34. PubMed ID: 25657336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
